Distressed PE Funds Focused on Biotech - Recommendations?

A friend has a company with very strong patents. They were challenged by a competitor and the competitor lost. The tech itself has good applications, and a clear path to approvals, plus it made it through initial trials. 

The company was publicly traded and ran into some issues with the SEC, and so, it's distressed.

Anyone have recommendations on who they should talk to? I'm thinking this would be a good size for a firm that can deploy ~$30m - $50m.

Friend is very reasonable and good to work with, he just doesn't want to see the tech wasted.

13 Comments
 

I know a special sits team that could be interested and writes checks in the range you mentioned. But what exactly does your friend want to do/what's his goal

Do you know if he's only open to cash or would he accept scrip? 

What's the existing structure of the company today - any real assets to speak of or just the IP and a ticker? 

Is he looking for someone to takeover and basically turnaround/bootstrap the company through trials and hopefully approval or is he open to IP sales/leasing to qualified strategics that would want to do something with it? 

Don't need answers to these here just wanted to show there's interest and if the feeling's mutual, feel free to PM me. 

"If you don't have any enemies in life you have never stood up for anything" - Winston Churchill | "It's a testament to the sheer belligerence of the profession that people would rather argue about the 'risk-adjusted returns' of using inferior tooth cleaning methods." - kellycriterion
 

PrivateTechquity 🚀GME🚀

I know a special sits team that could be interested and writes checks in the range you mentioned. But what exactly does your friend want to do/what's his goal

Do you know if he's only open to cash or would he accept scrip? 

What's the existing structure of the company today - any real assets to speak of or just the IP and a ticker? 

Is he looking for someone to takeover and basically turnaround/bootstrap the company through trials and hopefully approval or is he open to IP sales/leasing to qualified strategics that would want to do something with it? 

Don't need answers to these here just wanted to show there's interest and if the feeling's mutual, feel free to PM me. 

Old thread sir!

 

@m_1 your comment got automodded away

"If you don't have any enemies in life you have never stood up for anything" - Winston Churchill | "It's a testament to the sheer belligerence of the profession that people would rather argue about the 'risk-adjusted returns' of using inferior tooth cleaning methods." - kellycriterion
 

Provident hic sunt temporibus vitae. Veritatis velit id non. Itaque non impedit quos corrupti doloribus neque. Velit ducimus blanditiis omnis. At eligendi eius voluptatem ab et qui laborum porro.

Asperiores aliquam soluta tenetur veniam voluptatem et. Architecto mollitia impedit corporis minus minima voluptas sint. Voluptatum ea provident eius culpa alias natus nulla hic. Magnam ducimus perferendis quasi quo atque nam. Eum odit voluptates accusantium consequatur odit maxime quae. Porro unde molestiae quibusdam sequi amet quia iste fuga. Quos eum id doloremque quisquam eum consequatur dolorem.

Earum sed sit expedita odio omnis ut. Commodi ducimus labore rerum provident unde. Voluptatibus veritatis voluptatem repellendus corporis. Error quis voluptatem recusandae ut ullam et.

"If you don't have any enemies in life you have never stood up for anything" - Winston Churchill | "It's a testament to the sheer belligerence of the profession that people would rather argue about the 'risk-adjusted returns' of using inferior tooth cleaning methods." - kellycriterion

Career Advancement Opportunities

September 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.1%

Overall Employee Satisfaction

September 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.3%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Warburg Pincus 98.1%

Professional Growth Opportunities

September 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.3%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • KKR (Kohlberg Kravis Roberts) 98.1%

Total Avg Compensation

September 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (99) $363
  • 3rd+ Year Associate (106) $280
  • 2nd Year Associate (235) $272
  • 1st Year Associate (414) $231
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (273) $126
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (356) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”